How can we provide better support for junior investigators who are transitioning from K Award to R Award funding?

The apheresis medicine encompasses treatment of numerous diseases many of which are directly related to blood, lung and heart. However, there are very limited opportunities for training young investigators in basic and translational research related to Apheresis Medicine. There is a need to promote Apheresis Medicine as a viable field of research for junior and established investigators. The influx of well-trained junior... more »

To ensure continuity of mentorship across generations, should we create incentives to encourage participation of younger, junior faculty in the leadership of our T32 programs?

To ensure that young investigators remain in the field, the National Institutes of Health should consider strategies for assisting these investigators in making the career and funding move from mentored career development awards and career development awards for independent investigators (K awards) to research awards (including but not limited to R01 awards).

What is the best way for the mentoring effort of senior investigators to be encouraged, enhanced, and supported to develop early career investigators?

We need to increase our base of T4 implementation research expertise among researchers, reviewers, and investigators.

What incentives will encourage current and new NHLBI investigators to pursue late translation (T4) research of proven effective interventions in heart, lung, blood, and sleep diseases? One of NHLBI’s current strategic plan’s goals is to translate discovery and early translation research knowledge to late stage T4 translation for use in populations so that it has significant positive health impacts and provides a return... more »

How can training of investigators (both mentors and trainees) be supported to create a T4 translation research pipeline?